Introduction {#H1-1-ZOI190504}
============

The American Heart Association (AHA) proposed the Life's Simple 7 (LS7) set of risk factors used to indicate cardiovascular health.^[@zoi190504r1]^ The LS7 comprises 7 ideal metrics, including 3 ideal health factors: untreated systolic blood pressure (BP) less than 120 and diastolic BP less than 80 mm Hg, untreated total cholesterol level less than 200 mg/dL (to convert to millimoles per liter, multiply by 0.0259), and untreated fasting blood glucose concentration less than 100 mg/dL (to convert to millimoles per liter, multiply by 0.0555). The LS7 also includes 4 ideal health behaviors: not smoking, maintaining a body mass index (BMI; calculated as weight in kilograms divided by height in meters squared) less than 25, achievement of a goal physical activity level, and a diet meeting 4 to 5 target components (recommended consumption levels of fruits and vegetables, fish, fiber-rich whole grains, sodium, and sugar-sweetened beverages).^[@zoi190504r1]^ In previous studies, adherence to the ideal LS7 metrics was found to be associated with decreased risks of cardiovascular disease (CVD),^[@zoi190504r2]^ all-cause mortality,^[@zoi190504r3]^ and cancer.^[@zoi190504r4]^

However, further consideration suggests that a reconstruction of the LS7 metrics should include additional factors. For example, although the AHA-proposed LS7 metrics include a BMI of less than 25 (a commonly used surrogate for normal weight),^[@zoi190504r1]^ this measure is prone to misclassification, especially in older populations.^[@zoi190504r5],[@zoi190504r6]^ Central obesity, which is defined by the waist to hip ratio (WHR), is a more sensitive marker of body fat distribution that is associated with higher mortality independent of BMI.^[@zoi190504r2]^ Furthermore, the 2015 to 2020 Dietary Guidelines for Americans,^[@zoi190504r7]^ which provide updated evidence relevant to reducing the cardiovascular risk and additional recommendations for adopting a healthy diet and lifestyle, recommend an integrated dietary pattern (Healthy Eating Index--2010). Moreover, the new 2017 American College of Cardiology/American Heart Association guideline has defined a new threshold for hypertension as a BP greater than or equal to 130/80 mm Hg.^[@zoi190504r8]^ Accordingly, we included modified weight, diet, and BP criteria in a revised set of LS7 metrics with an intention to more efficiently assess cardiovascular health in populations.

We used nationally representative data from the US National Health and Nutrition Examination Surveys (NHANES) from 1988 to 2016 to estimate national trends in the revised LS7 metrics among US adults aged 20 years and older. We also evaluated the individual and combined associations of the revised LS7 metrics on all-cause and cause-specific (eg, cancer and CVD) mortality and estimated the population-attributable fractions (PAF) associated with adherence to each ideal revised LS7 metric and the combination thereof. The comparison with the AHA-recommended LS7 metrics was also investigated.

Methods {#H1-2-ZOI190504}
=======

Study Population {#H2-1-ZOI190504}
----------------

The NHANES is an ongoing, multistage, cross-sectional survey. Two data sets were used: NHANES III, conducted from 1988 to 1994,^[@zoi190504r8]^ and the continuous NHANES survey, with data collected from 1999 to 2016. The National Center for Health Statistics Research Ethics Review Board reviewed and approved NHANES, and informed consent was obtained for all participants. This survey uses a complex, stratified, multistage probability sampling design to deliver nationally representative data on the health and nutritional status of the noninstitutionalized civilian population across the United States. Specifically, the NHANES obtains abundant information about a range of health topics through in-home interviews that address demographic, socioeconomic, dietary, and health-related questions, followed by blood sampling at a mobile examination center. The Medical School of Ningbo University Review Board determined that the current study was exempt from review and patient informed consent given the use of publicly available data. This study followed the Strengthening the Reporting of Observational Studies in Epidemiology ([STROBE](http://www.equator-network.org/reporting-guidelines/strobe/)) guideline for cross-sectional studies.

Our study is based on an analysis of data from the survey cycles corresponding to NHANES III (1988-1994), 1999 to 2004, 2005 to 2010, and 2011 to 2016. Participants with a BMI less than 18.5 or a history of heart attack, congestive heart failure, stroke, skin cancer, and other cancers were excluded because these factors are associated with a higher risk of mortality.^[@zoi190504r9],[@zoi190504r10]^ Participants who were pregnant or who were younger than 20 years were also excluded.

Definitions of the Revised LS7 Metrics {#H2-2-ZOI190504}
--------------------------------------

### Smoking Status {#H3-1-ZOI190504}

Current smokers were defined as those who answered yes to the following questions: "Do you smoke cigarettes now?" and "Have you smoked at least 100 cigarettes in your lifetime?" Former smokers included those who responded no to the first question but yes to the second. Never smokers were those who responded no to both questions. The status of never smokers, former smokers, and current smokers was defined as ideal, intermediate, and poor, respectively ([Table 1](#zoi190504t1){ref-type="table"}).

###### Definitions of Ideal, Intermediate, and Poor LS7 Metrics for Adults

  Goal/Metric                                                        AHA Definitions of LS7 Metrics[^a^](#zoi190504t1n1){ref-type="table-fn"}            Definitions for Revised LS7 Metrics                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
  ------------------------------------------------------------------ ----------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Smoking Status**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
  Ideal                                                              Never or quit \>12 mo ago                                                           Survey did not ask the time since quitting smoking; we included the participants who self-reported never smoking in the ideal category for consistent estimates across the surveys                                                                                                                                                                                                                   Survey asked the time since quitting smoking; to be consistent with NHANES III estimate, we included the participants who self-reported never smoking in the ideal category                                                                                         Survey asked the time since quitting smoking; to be consistent with NHANES III estimate, we included the participants who self-reported never smoking in the ideal category                                                                                         Survey asked the time since quitting smoking; to be consistent with NHANES III estimate, we included the participants who self-reported never smoking in the ideal category
  Intermediate                                                       Former or quit ≤12 mo                                                               Included all former smokers                                                                                                                                                                                                                                                                                                                                                                          Included all former smokers                                                                                                                                                                                                                                         Included all former smokers                                                                                                                                                                                                                                         Included all former smokers
  Poor                                                               Current smoking                                                                     Current smoking                                                                                                                                                                                                                                                                                                                                                                                      Current smoking                                                                                                                                                                                                                                                     Current smoking                                                                                                                                                                                                                                                     Current smoking
  **BMI-WHR**[^b^](#zoi190504t1n2){ref-type="table-fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
  1                                                                  BMI \<25                                                                            BMI ≤24.9 and WHR \<0.9 for men; BMI ≤24.9 and WHR\<0.8 for women                                                                                                                                                                                                                                                                                                                                    NA                                                                                                                                                                                                                                                                  NA                                                                                                                                                                                                                                                                  NA
  2                                                                  BMI 25-29.9                                                                         BMI ≤24.9 and WHR \<1 for men; BMI ≤24.9 and WHR \<0.92 for women                                                                                                                                                                                                                                                                                                                                    NA                                                                                                                                                                                                                                                                  NA                                                                                                                                                                                                                                                                  NA
  3                                                                  BMI ≥30.0                                                                           BMI ≤24.9 and WHR \>1 for men; BMI ≤24.9 and WHR \>0.92 for women                                                                                                                                                                                                                                                                                                                                    NA                                                                                                                                                                                                                                                                  NA                                                                                                                                                                                                                                                                  NA
  4                                                                                                                                                      BMI ≤29.9 and WHR\<0.9 for men; BMI ≤29.9 and WHR\<0.8 for women                                                                                                                                                                                                                                                                                                                                     NA                                                                                                                                                                                                                                                                  NA                                                                                                                                                                                                                                                                  NA
  5                                                                                                                                                      BMI ≤29.9 and WHR \<1 for men; BMI ≤29.9 and WHR \<0.92 for women                                                                                                                                                                                                                                                                                                                                    NA                                                                                                                                                                                                                                                                  NA                                                                                                                                                                                                                                                                  NA
  6                                                                                                                                                      BMI ≤29.9 and WHR \>1 for men; BMI ≤29.9 and WHR \>0.92 for women                                                                                                                                                                                                                                                                                                                                    NA                                                                                                                                                                                                                                                                  NA                                                                                                                                                                                                                                                                  NA
  7                                                                                                                                                      BMI ≥30 and WHR \<0.9 for men; BMI ≥30 and WHR \<0.8 for women                                                                                                                                                                                                                                                                                                                                       NA                                                                                                                                                                                                                                                                  NA                                                                                                                                                                                                                                                                  NA
  8                                                                                                                                                      BMI ≥30 and WHR \<1 for men; BMI ≥30 and WHR \<0.92 for women                                                                                                                                                                                                                                                                                                                                        NA                                                                                                                                                                                                                                                                  NA                                                                                                                                                                                                                                                                  NA
  9                                                                                                                                                      BMI ≥30 and WHR \>1 for men; BMI ≥30 and WHR \>0.92 for women                                                                                                                                                                                                                                                                                                                                        NA                                                                                                                                                                                                                                                                  NA                                                                                                                                                                                                                                                                  NA
  **Physical Activity**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
  Ideal                                                              ≥150 min/wk moderate or ≥75 min/wk vigorous or ≥150 min/wk moderate + vigorous      NHANES III did not ask the duration of physical activities; we defined physically active as engaging in physical activities with 3≤METS\<6 and ≥5 times/wk or physical activities with METS ≥6 and 3.0 times/wk. Physical activities included walking, jogging or running, bicycling, swimming, aerobics or aerobic dancing, other dancing, calisthenics, gardening or yard work, and other sports   ≥150 min/wk moderate or ≥75 min/wk vigorous or ≥150 min/wk moderate + vigorous; physical activities included walking, jogging or running, bicycling, swimming, aerobics or aerobic dancing, other dancing, calisthenics, gardening or yard work, and other sports   ≥150 min/wk moderate or ≥75 min/wk vigorous or ≥150 min/wk moderate + vigorous; physical activities included walking, jogging or running, bicycling, swimming, aerobics or aerobic dancing, other dancing, calisthenics, gardening or yard work, and other sports   ≥150 min/wk moderate or ≥75 min/wk vigorous or ≥150 min/wk moderate + vigorous; physical activities included walking, jogging or running, bicycling, swimming, aerobics or aerobic dancing, other dancing, calisthenics, gardening or yard work, and other sports
  Intermediate                                                       1-149 min/wk moderate or 1-74 min/wk vigorous or 1-149 min/wk moderate + vigorous   The difference between physically active and no physical activity was taken as intermediate                                                                                                                                                                                                                                                                                                          1-149 min/wk moderate or 1-74 min/wk vigorous or 1-149 min/wk moderate + vigorous                                                                                                                                                                                   1-149 min/wk moderate or 1-74 min/wk vigorous or 1-149 min/wk moderate + vigorous                                                                                                                                                                                   1-149 min/wk moderate or 1-74 min/wk vigorous or 1-149 min/wk moderate + vigorous
  Poor                                                               None                                                                                None                                                                                                                                                                                                                                                                                                                                                                                                 None                                                                                                                                                                                                                                                                None                                                                                                                                                                                                                                                                None
  **Healthy Diet Score**[^c^](#zoi190504t1n3){ref-type="table-fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
  Ideal                                                              4-5 Components[^d^](#zoi190504t1n4){ref-type="table-fn"}                            Healthy eating index score ≥69.3                                                                                                                                                                                                                                                                                                                                                                     Healthy eating index score ≥69.3                                                                                                                                                                                                                                    Healthy eating index score ≥69.3                                                                                                                                                                                                                                    Healthy eating index score ≥69.3
  Intermediate                                                       2-3 Components[^d^](#zoi190504t1n4){ref-type="table-fn"}                            Healthy eating index score 56.9-69.2                                                                                                                                                                                                                                                                                                                                                                 Healthy eating index score 56.9-69.2                                                                                                                                                                                                                                Healthy eating index score 56.9-69.2                                                                                                                                                                                                                                Healthy eating index score 56.9-69.2
  Poor                                                               0-1 Components[^d^](#zoi190504t1n4){ref-type="table-fn"}                            Healthy eating index score \<56.9                                                                                                                                                                                                                                                                                                                                                                    Healthy eating index score \<56.9                                                                                                                                                                                                                                   Healthy eating index score \<56.9                                                                                                                                                                                                                                   Healthy eating index score \<56.9
  **Total Cholesterol**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
  Ideal                                                              \<200 mg/dL                                                                         \<200 mg/dL                                                                                                                                                                                                                                                                                                                                                                                          \<200 mg/dL                                                                                                                                                                                                                                                         \<200 mg/dL                                                                                                                                                                                                                                                         \<200 mg/dL
  Intermediate                                                       200-239 mg/dL or treated to goal                                                    200-239 mg/dL or treated to goal                                                                                                                                                                                                                                                                                                                                                                     200-239 mg/dL or treated to goal                                                                                                                                                                                                                                    200-239 mg/dL or treated to goal                                                                                                                                                                                                                                    200-239 mg/dL or treated to goal
  Poor                                                               ≥240 mg/dL                                                                          ≥240 mg/dL                                                                                                                                                                                                                                                                                                                                                                                           ≥240 mg/dL                                                                                                                                                                                                                                                          ≥240 mg/dL                                                                                                                                                                                                                                                          ≥240 mg/dL
  **Blood Pressure**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
  Ideal[^e^](#zoi190504t1n5){ref-type="table-fn"}                    SBP \<120/DBP \<80 mm Hg                                                            SBP \<120/DBP \<80 mm Hg                                                                                                                                                                                                                                                                                                                                                                             SBP \<120/DBP \<80 mm Hg                                                                                                                                                                                                                                            SBP \<120/DBP \<80 mm Hg                                                                                                                                                                                                                                            SBP \<120/DBP \<80mmHg
  Intermediate                                                       SBP 120-139 or DBP 80-89 mm Hg or treated to goal                                   SBP 120-129 or DBP \<80 mm Hg or treated to goal                                                                                                                                                                                                                                                                                                                                                     SBP 120-129 or DBP \<80 mm Hg or treated to goal                                                                                                                                                                                                                    SBP 120-129 or DBP \<80 mm Hg or treated to goal                                                                                                                                                                                                                    SBP 120-129 or DBP \<80 mm Hg or treated to goal
  Poor                                                               SBP ≥140 or DBP ≥90 mm Hg                                                           SBP ≥130 or DBP ≥80 mm Hg                                                                                                                                                                                                                                                                                                                                                                            SBP ≥130 or DBP ≥80 mm Hg                                                                                                                                                                                                                                           SBP ≥130 or DBP ≥80 mm Hg                                                                                                                                                                                                                                           SBP ≥130 or DBP ≥80 mm Hg
  **Fasting Plasma Glucose**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
  Ideal                                                              \<100 mg/dL                                                                         \<100 mg/dL; fasting glucose was available for a subsample of NHANES III participants (n = 6939)                                                                                                                                                                                                                                                                                                     \<100 mg/dL; fasting glucose was available for a subsample of NHANES 1999-2004 participants (n = 5635)                                                                                                                                                              \<100 mg/dL; fasting glucose was available for a subsample of NHANES 2005-2010 participants (n = 4124)                                                                                                                                                              \<100 mg/dL; fasting glucose was available for a subsample of NHANES 2011-2014 participants (n = 6205)
  Intermediate                                                       100-125 mg/dL or treated to goal                                                    100-125 mg/dL or treated to goal                                                                                                                                                                                                                                                                                                                                                                     100-125 mg/dL or treated to goal                                                                                                                                                                                                                                    100-125 mg/dL or treated to goal                                                                                                                                                                                                                                    100-125 mg/dL or treated to goal
  Poor                                                               ≥126 mg/dL                                                                          ≥126 mg/dL                                                                                                                                                                                                                                                                                                                                                                                           ≥126 mg/dL                                                                                                                                                                                                                                                          ≥126 mg/dL                                                                                                                                                                                                                                                          ≥126 mg/dL

Abbreviations: AHA, American Heart Association; BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); DBP, diastolic blood pressure; LS7, Life's Simple 7; METS, metabolic equivalent score; NA, not available; NHANES, National Health and Nutrition Examination Survey; SBP, systolic blood pressure; WHR, waist to hip ratio.

SI conversion factors: To convert cholesterol to mmol/L, multiply by 0.0259; fasting plasma glucose to mmol/L, multiply by 0.0555.

According to the AHA Strategic Impact Goal.^[@zoi190504r1]^

The classification of BMI combined with WHR was based on the work of Sahakyan et al.^[@zoi190504r2]^ Category 3 BMI-WHR (normal weight with central obesity) was defined as poor.

The healthy diet score was calculated based on the Healthy Eating Index--2010, a measure of diet quality comprising 12 components. Nine components assess dietary adequacy (intakes of total fruit, whole fruit, total vegetables, greens and beans, whole grains, dairy, total protein foods, and seafood and plant proteins and fatty acid ratio), with higher scores indicating higher consumption. Three components assess dietary components that should be consumed in moderation (refined grains, sodium, and empty calories), with higher scores indicating lower consumption.

The first dietary metrics include fruits and vegetables (≥4.5 cups per day), fish (2 or more 3.5-oz servings per week \[preferably oily fish\]), fiber-rich whole grains (3 or more 1-oz-equivalent servings per day), sodium (\<1500 mg per day), and sugar-sweetened beverages (≤450 kcal \[36 oz\] per week). The secondary dietary metrics include nuts, legumes, and seeds (≥4 servings per week); processed meats (none or ≤2 servings per week); and saturated fat (\<7% of total energy intake).

Untreated values, ie, no hypertension or high cholesterol levels.

### Physical Activity {#H3-2-ZOI190504}

Prior to 1999, the NHANES III (1988-1994) assessed physical activity as the monthly frequency of participation in the following types of leisure-time physical activity: walking, jogging, biking, swimming, calisthenics, gardening, weight lifting, aerobics, dancing, and up to 4 additional activities. However, the NHANES III did not collect data about activity duration. Responses were standardized as times per week using the conversion factors 4.3 weeks per month and 30.4 days per month and rounded to the nearest whole number. Each activity was then assigned a metabolic equivalent score using a standardized coding scheme. Physical activity was calculated as the sum of the intensity rating multiplied by the times (of each activity) per week. For the NHANES III (1988-1994), ideal physical activity (physically active) was defined using the following cutoffs: a metabolic equivalent score of 3.0 to 5.9 and participation 5 or more times per week, or a metabolic equivalent score of 6.0 or greater and participation 3 or more times per week ([Table 1](#zoi190504t1){ref-type="table"}).^[@zoi190504r11],[@zoi190504r12]^

After 1999, participants were categorized into ideal, intermediate, or poor leisure-time physical activity levels based on whether they met the following recommendations for weekly activity: ideal, 75 minutes or more of vigorous activity or 150 minutes or more of moderate activity or 150 minutes or more of combined moderate and vigorous physical activity; intermediate, more than 0 minutes of physical activity but less than recommendations; and poor, 0 minutes of physical activity ([Table 1](#zoi190504t1){ref-type="table"}).

### Diet {#H3-3-ZOI190504}

The NHANES 1988 to 2016 estimated the Healthy Eating Index--2010 from 2 nonconsecutive 24-hour recall periods.^[@zoi190504r13]^ The total healthy diet score ranged from 0 to 100, with greater scores indicating superior diet quality. This measure was grouped into tertiles: ideal, greater than 69.3; intermediate, 56.9 to 69.3; and poor, less than 56.9 ([Table 1](#zoi190504t1){ref-type="table"}).

### BMI and WHR {#H3-4-ZOI190504}

We used a sex-stratified composite classification of the BMI and WHR to account for sex-stratified differences within the same cohort.^[@zoi190504r14]^ The detailed classifications are shown in eTable 1 in the [Supplement](#note-ZOI190504-1-s){ref-type="supplementary-material"}. A BMI-WHR level of 3 or greater (normal weight with central obesity) was defined as poor; all other levels were defined as ideal.^[@zoi190504r14]^ The NHANES 1999 to 2016 did not measure hip circumference, and therefore the WHR is not available for the NHANES 1999 to 2004, 2005 to 2010, and 2011 to 2016. Different combinations of the WHR and BMI were only available for NHANES III (1988-1994) ([Table 1](#zoi190504t1){ref-type="table"}).

### Hypertension {#H3-5-ZOI190504}

The new 2017 American College of Cardiology/American Heart Association guideline updated the threshold for hypertension to a BP of 130/80 mm Hg or greater.^[@zoi190504r8]^ An untreated BP less than 120/80 mm Hg was defined as ideal ([Table 1](#zoi190504t1){ref-type="table"}).

### Cholesterol {#H3-6-ZOI190504}

An untreated total cholesterol level less than 200 mg/dL was defined as ideal. This value was identical to the AHA definition of ideal total cholesterol ([Table 1](#zoi190504t1){ref-type="table"}).

### Fasting Plasma Glucose {#H3-7-ZOI190504}

Hemoglobin A~1c~ values of less than 5.7% and less than 6.0% (to convert to proportion of total hemoglobin, multiply by 0.01) were used as proxies for fasting glucose levels less than 100 and less than 125 mg/dL, respectively. An untreated fasting blood glucose level of less than 100 mg/dL was defined as ideal ([Table 1](#zoi190504t1){ref-type="table"}).

Revised Combined LS7 Metrics {#H2-3-ZOI190504}
----------------------------

Each revised LS7 metric was coded as 2 if categorized as ideal, 1 if categorized as intermediate, and 0 if categorized as poor. Category 3 BMI-WHR (normal weight with central obesity) was defined as poor. The points for all revised LS7 metrics were then summed. Details of the cutoff values for each revised LS7 metric are described in [Table 1](#zoi190504t1){ref-type="table"}. Participants with all available revised LS7 metrics were included in our study.

Assessment of Outcomes {#H2-4-ZOI190504}
----------------------

The primary outcome was all-cause mortality, and the secondary outcomes were cause-specific (cancer and CVD) mortality. Participants in the NHANES III (1988-1994) were prospectively followed from the date of enrollment until December 31, 2011.^[@zoi190504r15]^ The National Center for Health Statistics ascertained mortality data from National Death Index death certificate records by matching the following data: Social Security number, name, date of birth, race/ethnicity, sex, state of birth, and state of residence.^[@zoi190504r16]^ The cause of death was classified as cancer (*International Statistical Classification of Diseases and Related Health Problems, Tenth Revision* codes C00-C97) or CVD (codes I00-I09, I11, I13, I20-I51).

Statistical Analysis {#H2-5-ZOI190504}
--------------------

The baseline characteristics and revised LS7 metrics are reported as weighted prevalence values and confidence intervals. The person-years at risk were calculated from the baseline date to death, loss to follow-up, or December 31, 2011, whichever came first. Trends were tested using a logistic regression analysis that included a time variable equal to the median of the cycles after adjusting for age, sex, and race/ethnicity. Standard errors were estimated using Taylor series linearization.^[@zoi190504r17]^

Participants in the NHANES III (1988-1994) were used for the association analysis. Cox proportional hazards models were used to estimate the hazard ratios (HRs) and 95% confidence intervals for single and combined revised LS7 metrics after adjusting for age, sex, and race/ethnicity. Additional adjustments included education (\<12 or ≥12 years), alcohol intake (0, \<3, or ≥3 drinks per week; 1 drink was defined as 12 oz of beer, 4 oz of wine, or 1 oz of hard liquor), smoking, physical activity, BMI, WHR, healthy diet score, total cholesterol, systolic BP, diastolic BP, and hemoglobin A~1c~ values. For additional adjustment, when we investigated the association between each revised LS7 metric and outcomes, the relevant variables were excluded. For example, when the association between goal levels of untreated BP and outcomes was analyzed, systolic BP and diastolic BP were not included in the model.

Kaplan-Meier curves for all-cause and cause-specific mortality were generated using the numbers of ideal revised LS7 metrics and compared using the log-rank test. Proportional hazards assumptions were evaluated by statistically testing the significance of time-dependent interaction terms. Derivations from proportionality were not observed.

The PAF describes the attributable risk of mortality during follow-up due to nonadherence to each revised LS7 metric and the revised combined metrics, with adjustment for age and sex.^[@zoi190504r18]^ The sensitivity analyses were stratified by sex (male or female), age (\<60 or ≥60 years), race/ethnicity (non-Hispanic white, non-Hispanic black, Mexican American, or other), education (\<12 or ≥12 years), and alcohol drinking (0, \<3, or ≥3 drinks per week). Interactions were performed using the likelihood ratio test with and without the cross-product interaction term. Another sensitivity analysis excluding death during the first 5 years of follow-up was conducted to assess whether the results had been influenced by reverse causation.

Sample weights were used for all analyses. Data were analyzed using SAS statistical software version 9.4 (SAS Institute). Statistical significance was set at *P* \< .05 using a 2-sided test.

Results {#H1-3-ZOI190504}
=======

Data were available for 13 606 adults in NHANES III (1988-1994) (7329 \[53%\] female; mean \[SD\] age, 47 \[17.7\] years), 6360 in 1999 to 2004 (3442 \[54%\] female; mean \[SD\] age, 47 \[18.6\] years), 10 618 in 2005 to 2010 (5428 \[51%\] female; mean \[SD\] age, 47 \[17.5\] years), and 10 773 in 2011 to 2016 (5474 \[50%\] female; mean \[SD\] age, 48 \[17.4\] years). Participants in the NHANES III (1988-1994), who were younger, female, more educated, more likely to be non-Hispanic white, and less likely to consume alcohol than participants in other cycles, were more likely to have a greater number of ideal revised LS7 metrics (eTable 2 in the [Supplement](#note-ZOI190504-1-s){ref-type="supplementary-material"}).

The characteristic distributions of the revised LS7 metrics for all survey cycles are shown in [Table 2](#zoi190504t2){ref-type="table"} and eTable 3 in the [Supplement](#note-ZOI190504-1-s){ref-type="supplementary-material"}. Generally, less than 1% of the participants met all 6 to 7 ideal revised LS7 metrics, while approximately 21.8% to 30.7% met 2 or 3 of the ideal metrics ([Table 2](#zoi190504t2){ref-type="table"}). From NHANES III (1988-1994) to 2011 to 2016, the weighted prevalence values of never smoking increased, whereas those of the ideal physical activity level, healthy diet score, and untreated fasting blood glucose level less than 100 mg/dL decreased ([Table 2](#zoi190504t2){ref-type="table"}).

###### Weighted Prevalence of Meeting Revised Life\'s Simple 7 Metrics in Adults, NHANES III (1988-1994), 1999-2004, 2005-2010, and 2011-2016

  Life\'s Simple 7 Metrics[^a^](#zoi190504t2n1){ref-type="table-fn"}       NHANES III, 1988-1994   NHANES 1999-2004   NHANES 2005-2010   NHANES 2011-2016   *P* for Trend[^b^](#zoi190504t2n2){ref-type="table-fn"}                                                
  ------------------------------------------------------------------------ ----------------------- ------------------ ------------------ ------------------ --------------------------------------------------------- ------------------ ------ ------------------ --------
  Smoking status                                                                                                                                                                                                                                                   
  Never                                                                    6731                    46.0 (44.3-47.7)   3460               53.1 (50.2-56.0)   6023                                                      56.4 (54.4-58.3)   6679   61.0 (59.4-62.5)   \<.001
  Former                                                                   3245                    24.4 (23.1-25.7)   1680               25.0 (22.7-27.1)   2484                                                      23.2 (21.9-24.4)   2287   23.0 (21.6-24.4)   \<.001
  Current                                                                  3630                    29.4 (27.7-31.1)   1220               21.9 (19.9-23.7)   2111                                                      20.4 (18.8-21.9)   1807   16.0 (14.6-17.2)   \<.001
  Physical activity[^c^](#zoi190504t2n3){ref-type="table-fn"}                                                                                                                                                                                                      
  Ideal                                                                    4008                    31.0 (29.0-33.1)   992                16.7 (14.9-18.3)   459                                                       5.00 (4.27-5.76)   2749   27.6 (26.2-29.0)   \<.001
  Intermediate                                                             6718                    54.9 (53.2-56.5)   2506               47.0 (44.7-49.1)   1433                                                      17.8 (15.3-20.1)   2842   29.8 (28.0-31.4)   \<.001
  Poor                                                                     2880                    14.0 (12.4-15.5)   2862               36.3 (33.7-38.9)   8726                                                      77.2 (74.4-79.9)   5182   42.6 (40.2-44.8)   \<.001
  BMI-WHR[^d^](#zoi190504t2n4){ref-type="table-fn"}                                                                                                                                                                                                                
  1                                                                        1839                    17.2 (15.8-18.6)   NA                 NA                 NA                                                        NA                 NA     NA                 NA
  2                                                                        2792                    23.4 (22.2-24.7)   NA                 NA                 NA                                                        NA                 NA     NA                 NA
  3                                                                        639                     3.89 (3.35-4.43)   NA                 NA                 NA                                                        NA                 NA     NA                 NA
  4                                                                        507                     4.21 (3.59-4.83)   NA                 NA                 NA                                                        NA                 NA     NA                 NA
  5                                                                        2542                    18.9 (18.0-19.9)   NA                 NA                 NA                                                        NA                 NA     NA                 NA
  6                                                                        1753                    10.0 (9.27-10.8)   NA                 NA                 NA                                                        NA                 NA     NA                 NA
  7                                                                        151                     1.09 (0.83-1.35)   NA                 NA                 NA                                                        NA                 NA     NA                 NA
  8                                                                        1501                    9.83 (9.00-10.6)   NA                 NA                 NA                                                        NA                 NA     NA                 NA
  9                                                                        1882                    11.1 (10.4-11.9)   NA                 NA                 NA                                                        NA                 NA     NA                 NA
  Healthy diet score[^e^](#zoi190504t2n5){ref-type="table-fn"}                                                                                                                                                                                                     
  \>69.3                                                                   4255                    33.9 (32.2-35.6)   413                6.00 (4.89-6.97)   1248                                                      11.9 (10.6-13.1)   1447   13.9 (12.8-15.1)   \<.001
  56.9-69.3                                                                4521                    32.9 (31.3-34.5)   1070               14.8 (13.2-16.4)   2459                                                      22.7 (21.4-23.9)   2414   22.9 (21.7-24.2)   \<.001
  \<56.9                                                                   4830                    33.0 (31.0-35.0)   4877               79.2 (76.9-81.4)   6911                                                      65.4 (63.2-67.5)   6912   63.0 (61.1-64.8)   \<.001
  Total serum cholesterol, mg/dL                                                                                                                                                                                                                                   
  \<200 (Untreated)[^f^](#zoi190504t2n6){ref-type="table-fn"}              6853                    51.4 (49.4-53.4)   2905               47.2 (45.2-49.1)   5292                                                      50.1 (48.6-51.4)   5822   53.3 (51.5-55.1)   \<.001
  200-239 or treated to goal                                               4115                    30.0 (28.6-31.5)   2275               34.6 (33.0-36.1)   3574                                                      33.4 (32.1-34.6)   3476   32.5 (31.0-33.9)   .68
  ≥240                                                                     2638                    18.4 (17.1-19.7)   1180               18.2 (16.7-19.6)   1752                                                      16.5 (15.5-17.5)   1475   14.2 (13.2-15.1)   \<.001
  Blood pressure, mm Hg                                                                                                                                                                                                                                            
  \<120/80 (Untreated)[^f^](#zoi190504t2n6){ref-type="table-fn"}           5470                    46.3 (44.3-48.2)   2300               42.5 (40.1-44.7)   4569                                                      46.7 (45.0-48.3)   4758   47.2 (45.4-49.0)   \<.001
  SBP 120-129 or DBP \<80 or treated to goal                               5120                    33.7 (32.1-35.2)   2751               37.5 (35.7-39.3)   4306                                                      37.3 (35.8-38.8)   4290   38.0 (36.2-39.6)   .13
  SBP ≥130 or DBP ≥80                                                      3016                    19.9 (18.6-21.2)   1309               20.0 (18.4-21.6)   1743                                                      16.0 (14.9-17.0)   1725   14.8 (13.5-16.1)   \<.001
  Fasting blood glucose, mg/dL[^g^](#zoi190504t2n7){ref-type="table-fn"}                                                                                                                                                                                           
  \<100                                                                    3451                    72.8 (70.3-75.4)   1970               67.4 (65.4-69.4)   2661                                                      57.3 (54.6-60.0)   1892   57.6 (54.9-60.3)   \<.001
  100-125                                                                  1582                    20.7 (18.8-22.7)   945                26.6 (24.6-28.5)   1951                                                      36.2 (33.7-38.8)   1238   35.2 (32.7-37.6)   \<.001
  ≥126                                                                     551                     6.33 (5.12-7.54)   283                6.00 (4.82-7.06)   488                                                       6.50 (5.58-7.32)   327    7.20 (5.96-8.41)   \<.001
  Ideal Life\'s Simple 7 metrics                                                                                                                                                                                                                                   
  0                                                                        562                     3.08 (2.71-3.46)   324                3.60 (2.94-4.25)   626                                                       4.40 (3.88-4.89)   199    1.70 (1.39-1.99)   .07
  1                                                                        1952                    11.7 (10.6-12.7)   1266               16.9 (15.3-18.4)   2101                                                      17.6 (16.3-18.7)   1322   11.8 (10.9-12.7)   .03
  2                                                                        3216                    21.8 (20.4-23.1)   1964               30.7 (28.9-32.5)   3084                                                      28.7 (27.6-29.7)   2865   25.4 (24.0-26.7)   \<.001
  3                                                                        3389                    25.0 (23.9-26.0)   1696               28.4 (26.6-30.1)   2895                                                      29.4 (28.5-30.3)   3251   30.3 (28.9-31.6)   \<.001
  4                                                                        2643                    21.5 (20.5-22.6)   930                17.0 (15.5-18.4)   1700                                                      17.4 (16.0-18.7)   2318   22.6 (28.9-31.6)   .23
  5                                                                        1349                    12.0 (10.8-13.2)   176                3.30 (2.42-4.09)   208                                                       2.50 (2.18-2.89)   732    7.20 (6.28-8.00)   \<.001
  6                                                                        427                     3.93 (3.23-4.62)   4                  0.10 (0-0.19)      4                                                         0 (0-0)            86     1.00 (0.79-1.28)   \<.001
  7[^h^](#zoi190504t2n8){ref-type="table-fn"}                              68                      0.81 (0.53-1.09)   NA                 NA                 NA                                                        NA                 NA     NA                 NA

Abbreviations: BMI-WHR, body mass index--waist hip ratio; DBP, diastolic blood pressure; NA, not available; NHANES, National Health and Nutrition Examination Survey; SBP, systolic blood pressure.

SI conversion factors: To convert total serum cholesterol to mmol/L, multiply by 0.0259; fasting blood glucose to mmol/L, mulitply by 0.0555.

All nonpregnant participants older than 20 years with available revised Life\'s Simple 7 metrics were included.

Trends across different surveys were analyzed by logistic regression model adjusted for age, sex, and race/ethnicity.

For the NHANES III (1988-1994), ideal physical activity (physically active) was defined using the following cutoffs: a metabolic equivalent score of 3 to 5.9 and participation 5 or more times per week, or a metabolic equivalent score of 6.0 or greater and participation 3 or more times per week. None was defined as poor. For the NHANES 1999 to 2014, 75 minutes or more of vigorous activity or 150 minutes or more of moderate activity or 150 minutes or more of combined moderate and vigorous physical activity; intermediate, more than 0 minutes of physical activity but less than recommendations; and poor, 0 minutes of physical activity. Physical activities included walking, jogging or running, bicycling, swimming, aerobics or aerobic dancing, other dancing, calisthenics, gardening or yard work, and other sports. The duration (minutes) of physical activity changed largely at NHANES 2007 to 2008; trend analysis was limited to NHANES 1999 to 2004 and NHANES 2005 to 2006.

A BMI-WHR level of 3 or greater (normal weight with central obesity) was defined as poor; all other levels were defined as ideal. The NHANES 1999 to 2016 did not measure hip circumference, and therefore the WHR is not available for the NHANES 1999 to 2004, 2005 to 2010, and 2011 to 2016. Different combinations of the WHR and BMI were only available for NHANES III (1988-1994).The classification of BMI combined with WHR was based on the work of Sahakyan et al.^[@zoi190504r2]^

The healthy diet score was calculated based on the healthy eating index advocated by Dietary Guidelines for Americans^[@zoi190504r7]^. The tertiles of the index were classified as ideal, intermediate, and poor, respectively.

Untreated value.

Fasting glucose level was available for a subgroup of participants in NHANES III (1988-1994) and NHANES 1999 to 2016. For trends, hemoglobin A~1c~ values less than 5.7% and 6.0% were used as proxies for fasting glucose levels less than 100 mg/dL and 125 mg/dL, respectively.

Values for WHR were not available in NHANES 1999-2016.

A total of 12 299 participants were included in the association analysis in NHANES III (1988-1994). Of these participants, 4569 died during a median (range) follow-up of 19.16 (14.91-20.75) years (3015 all-cause deaths, 695 cancer deaths, and 859 CVD deaths). The Kaplan-Meier survival curves for participants who met 0 to 1, 2, 3, 4, or 5 to 7 ideal revised LS7 metrics are presented in [Figure 1](#zoi190504f1){ref-type="fig"}. Participants who met 5 to 7 ideal revised LS7 metrics had significantly lower cumulative incidence rates of all-cause and cause-specific mortality compared with other groups (*P* \< .001 for all log-rank tests).

![All-Cause and Cause-Specific Mortality by Revised Life\'s Simple 7 (LS7) Metrics\
Data are from the National Health and Nutrition Examination Survey III (1988-1994) linked mortality file.](jamanetwopen-2-e1913131-g001){#zoi190504f1}

[Table 3](#zoi190504t3){ref-type="table"} and [Figure 2](#zoi190504f2){ref-type="fig"} and eFigure 1 and eFigure 2 in the [Supplement](#note-ZOI190504-1-s){ref-type="supplementary-material"} present the adjusted HRs for all mortality outcomes according to the revised LS7 metrics and AHA-recommended LS7 metrics.^[@zoi190504r3]^ Both metrics exhibited inverse dose-response associations with all-cause or cause-specific mortality (all *P* for trend \< .001), except the association between the AHA-recommended LS7 metrics and cancer mortality (*P* for trend = .10) ([Figure 2](#zoi190504f2){ref-type="fig"}). Compared with participants who met 0 to 1 of the ideal revised LS7 metrics, the adjusted HRs of participants who met at least 5 metrics were 0.46 (95% CI, 0.35-0.61) for all-cause mortality, 0.42 (95% CI, 0.25-0.68) for cancer mortality, and 0.37 (95% CI, 0.24-0.55) for CVD mortality ([Figure 2](#zoi190504f2){ref-type="fig"}). The adjusted HRs of participants who met 6 or more AHA-recommended ideal LS7 metrics were 0.49 (95% CI, 0.33-0.74) for all-cause mortality, 0.60 (95% CI, 0.29-1.25) for cancer mortality, and 0.24 (95% CI, 0.13-0.47) for CVD mortality ([Figure 2](#zoi190504f2){ref-type="fig"}).

###### Multivariable-Adjusted HRs and Population-Attributable Fractions for All-Cause and Cause-specific Mortality by Revised Life\'s Simple 7 Metrics[^a^](#zoi190504t3n1){ref-type="table-fn"}

  Factor                                                                   All-Cause Mortality   Cancer Mortality   CVD Mortality                                                                                                                                                                                                             
  ------------------------------------------------------------------------ --------------------- ------------------ --------------- ------------------ -------- ------------------ ---------- ------------------ -------- ------------------- -------- ------------------- ---------- ------------------ -------- ------------------ -------- ------------------
  Smoking status                                                                                                                                                15.2 (12.2-18.0)                                                                       28.83 (21.0-35.9)                                                                      10.7 (4.0-17.0)
  Current                                                                  833/3377              1 \[Reference\]                    1 \[Reference\]                                242/2786   1 \[Reference\]             1 \[Reference\]                                  199/2743   1 \[Reference\]             1 \[Reference\]             
  Former                                                                   933/2723              0.48 (0.41-0.56)   \<.001          0.47 (0.39-0.57)   \<.001                      218/2008   0.39 (0.29-0.54)   \<.001   0.41 (0.29-0.58)    \<.001                       275/2065   0.35 (0.26-0.47)   \<.001   0.29 (0.21-0.42)   \<.001   
  Never                                                                    1249/6199             0.41 (0.35-0.48)   \<.001          0.43 (0.37-0.50)   \<.001                      235/5185   0.25 (0.18-0.37)   \<.001   0.25 (0.17-0.36)    \<.001                       385/5335   0.33 (0.24-0.46)   \<.001   0.32 (0.22-0.47)   \<.001   
  Physical activity                                                                                                                                             4.26 (0.7-7.7)                                                                         NA                                                                                     5.91 (0.03-14.1)
  Poor                                                                     789/2437              1 \[Reference\]                    1 \[Reference\]                                163/1811   1 \[Reference\]             1 \[Reference\]                                  246/1894   1 \[Reference\]             1 \[Reference\]             
  Intermediate                                                             1300/6197             0.63 (0.54-0.73)   \<.001          0.79 (0.66-0.94)   .01                         304/5201   0.67 (0.48-0.95)   .03      1.04 (0.71-1.54)    .81                          350/5247   0.55 (0.43-0.72)   \<.001   0.74 (0.54-1.02)   .07      
  Ideal                                                                    926/3665              0.59 (0.52-0.68)   \<.001          0.82 (0.68-0.98)   .03                         228/2967   0.68 (0.47-0.97)   .04      1.19 (0.76-1.86)    .43                          263/3002   0.51 (0.39-0.65)   \<.001   0.68 (0.47-0.99)   .049     
  BMI-WHR[^e^](#zoi190504t3n5){ref-type="table-fn"}                                                                                                             16.61 (5.2-26.6)                                                                       NA                                                                                     NA
  3                                                                        307/526               1 \[Reference\]                    1 \[Reference\]                                54/273     1 \[Reference\]             1 \[Reference\]                                  108/327    1 \[Reference\]             1 \[Reference\]             
  1                                                                        154/1790              0.56 (0.37-0.84)   .006            0.69 (0.42-1.13)   .14                         40/1676    0.56 (0.29-1.09)   .09      0.87 (0.39-1.90)    .72                          41/1677    0.52 (0.28-0.95)   .03      0.77 (0.33-1.79)   .54      
  2                                                                        576/2530              0.70 (0.55-0.88)   .004            0.78 (0.58-1.05)   .11                         151/2105   0.80 (0.51-1.26)   .34      1.10 (0.68-1.80)    .68                          142/2096   0.55 (0.37-0.80)   .003     0.59 (0.37-0.94)   .03      
  4                                                                        43/482                0.63 (0.41-0.98)   .04             1.00 (0.58-1.73)   .98                         9/448      0.68 (0.26-1.76)   .42      1.40 (0.49-4.04)    .52                          11/450     0.55 (0.23-1.28)   .16      1.19 (0.43-3.24)   .73      
  5                                                                        385/2361              0.51 (0.39-0.66)   \<.001          0.61 (0.44-0.85)   .004                        87/2063    0.48 (0.28-0.84)   .01      0.70 (0.38-1.29)    .25                          104/2080   0.37 (0.22-0.63)   .001     0.44 (0.23-0.83)   .01      
  6                                                                        708/1472              0.81 (0.65-1.00)   .06             0.86 (0.68-1.10)   .24                         166/930    0.87 (0.50-1.53)   .64      1.16 (0.63-2.13)    .62                          200/964    0.67 (0.47-0.95)   .03      0.76 (0.52-1.10)   .15      
  7                                                                        15/142                0.71 (0.34-1.47)   .35             0.88 (0.43-1.79)   .72                         6/133      1.34 (0.35-5.09)   .65      1.96 (0.35-11.04)   .44                          3/130      0.30 (0.07-1.15)   .08      0.32 (0.06-1.58)   .16      
  8                                                                        259/1388              0.80 (0.63-1.02)   .07             0.91 (0.68-1.21)   .54                         65/1194    0.99 (0.58-1.69)   .97      1.31 (0.78-2.22)    .29                          69/1198    0.52 (0.32-0.84)   .01      0.50 (0.26-0.96)   .04      
  9                                                                        568/1608              1.00 (0.80-1.25)   .95             0.96 (0.73-1.26)   .76                         117/1157   1.00 (0.62-1.61)   .99      1.08 (0.63-1.85)    .76                          181/1221   0.92 (0.61-1.39)   .71      0.86 (0.51-1.45)   .57      
  Healthy diet score                                                                                                                                            8.0 (4.7-11.1)                                                                         11.7 (2.0-20.4)                                                                        NA
  \<56.9                                                                   1065/4426             1 \[Reference\]                    1 \[Reference\]                                258/3619   1 \[Reference\]             1 \[Reference\]                                  299/3660   1 \[Reference\]             1 \[Reference\]             
  56.9-69.3                                                                904/4119              0.81 (0.68-0.96)   .02             0.86 (0.73-1.01)   .08                         213/3428   0.80 (0.56-1.13)   .21      0.83 (0.59-1.18)    .32                          225/3440   0.80 (0.58-1.12)   .20      0.86 (0.60-1.24)   .43      
  ≥69.3                                                                    1046/3754             0.68 (0.59-0.78)   \<.001          0.81 (0.70-0.93)   .005                        224/2932   0.59 (0.43-0.81)   .002     0.72 (0.51-1.00)    .05                          335/3043   0.69 (0.56-0.85)   \<.001   0.91 (0.72-1.14)   .43      
  Total serum cholesterol, mg/dL                                                                                                                                NA                                                                                     NA                                                                                     10.1 (2.6-18.6)
  ≥240                                                                     848/2264              1 \[Reference\]                    1 \[Reference\]                                153/1569   1 \[Reference\]             1 \[Reference\]                                  290/1706   1 \[Reference\]             1 \[Reference\]             
  200-239 or treated to goal                                               1017/3661             1.04 (0.91-1.19)   .51             1.08 (0.93-1.25)   .29                         261/2905   1.68 (1.27-2.22)   \<.001   1.72 (1.26-2.36)    .001                         293/2937   0.90 (0.71-1.13)   .36      1.02 (0.81-1.28)   .86      
  \<200 (Untreated)                                                        1150/6374             1.14 (0.99-1.31)   .07             1.15 (0.99-1.33)   .06                         281/5505   1.66 (1.22-2.27)   .002     1.55 (1.09-2.21)    .02                          276/5500   0.89 (0.66-1.21)   .48      0.91 (0.65-1.28)   .62      
  Blood pressure, mm Hg                                                                                                                                         37.4 (32.8-42.5)                                                                       36.7 (26.8-28.9)                                                                       47.5 (38.2-57.3)
  SBP ≥130 or DBP ≥80                                                      938/2641              1 \[Reference\]                    1 \[Reference\]                                229/1932   1 \[Reference\]             1 \[Reference\]                                  289/1992   1 \[Reference\]             1 \[Reference\]             
  SBP 120-129 or DBP \<80 or treated to goal                               1615/4429             0.96 (0.83-1.11)   .65             0.99 (0.85-1.16)   .95                         336/3150   0.88 (0.61-1.29)   .53      0.82 (0.56-1.19)    .30                          482/3296   0.88 (0.70-1.10)   .26      0.83 (0.64-1.08)   .16      
  \<120/80 (Untreated)                                                     462/5229              0.66 (0.56-0.79)   \<.001          0.73 (0.61-0.88)   .002                        130/4897   0.67 (0.48-0.93)   .02      0.59 (0.41-0.84)    .004                         88/4855    0.49 (0.36-0.65)   \<.001   0.56 (0.38-0.81)   .003     
  Fasting blood glucose, mg/dL[^e^](#zoi190504t3n5){ref-type="table-fn"}                                                                                        6.8 (4.6-8.9)                                                                          2.8 (−3.2 to 8.6)                                                                      11.6 (6.1-16.8)
  ≥126                                                                     486/848               1 \[Reference\]                    1 \[Reference\]                                85/447     1 \[Reference\]             1 \[Reference\]                                  151/513    1 \[Reference\]             1 \[Reference\]             
  100-125                                                                  868/2376              0.60 (0.49-0.73)   \<.001          0.69 (0.54-0.87)   .003                        207/1715   0.65 (0.45-0.95)   .03      0.81 (0.52-1.27)    .37                          277/1785   0.49 (0.36-0.67)   \<.001   0.65 (0.47-0.91)   .01      
  \<100                                                                    1661/9075             0.46 (0.39-0.55)   \<.001          0.60 (0.47-0.76)   \<.001                      403/7817   0.53 (0.37-0.76)   .001     0.74 (0.45-1.21)    .23                          431/7845   0.37 (0.26-0.51)   \<.001   0.51 (0.35-0.75)   .001     

Abbreviations: BMI-WHR, body mass index--waist to hip ratio; DBP, diastolic blood pressure; HR, hazard ratio; NA, not available; NHANES, National Health and Nutrition Examination Survey; PAF, population-attributable fraction; SBP, systolic blood pressure.

SI conversion factors: To convert total serum cholesterol to mmol/L, multiply by 0.0259; fasting blood glucose to mmol/L, mulitply by 0.0555.

Data are from the NHANES III (1988-1994) linked mortality file. All nonpregnant participants older than 20 years with available revised Life\'s Simple 7 metrics were included.

Weighted prevalence and 95% CIs. Adjusted for age, sex, and race/ethnicity.

Weighted prevalence and 95% CIs. Adjusted for age, sex, race/ethnicity, educational attainment, alcohol intake, smoking status, physical activity, BMI, WHR, healthy diet score, total cholesterol level, SBP, DBP, and hemoglobin A~1c~ value as appropriate. For additional adjustment, when we investigate the association between each revised Life's Simple 7 metric and outcomes, the relevant variables were excluded; for example, when the association between goal levels of untreated blood pressure and outcomes was analyzed, SBP and DBP were not included in the model.

Adjusted for age and sex. The individual PAFs cannot be calculated for the Life\'s Simple 7 metrics with adjusted hazard ratios of 1.0 or greater.

The classification of BMI-WHR was based on the work of Sahakyan et al.^[@zoi190504r2]^

![Adjusted Hazard Ratios (HRs) and Population-Attributable Fractions (PAFs) for All-Cause and Cause-Specific Mortality by Revised Life\'s Simple 7 (LS7) Metrics and American Heart Association (AHA) LS7 Metrics\
Because a small proportion of participants met none or all of the LS7 metrics, the revised metrics were collapsed into 5 groups (0-1, 2, 3, 4, and 5-7). The PAF for the revised LS7 metrics was adjusted for age and sex. The PAF for the AHA-recommended LS7 metrics was adjusted for age, sex, race/ethnicity, educational attainment, alcohol intake, family history of cardiovascular disease (CVD), smoking status, physical activity, body mass index, healthy diet score, total cholesterol level, blood pressure, and hemoglobin A~1c~ value.](jamanetwopen-2-e1913131-g002){#zoi190504f2}

Of the individual revised LS7 metrics, never smoking and an untreated BP less than 120/80 mm Hg were associated with an independent lower risk for all outcomes. A BMI-WHR level of 5 (BMI ≤29.9 without central obesity) and untreated fasting blood glucose level less than 100 mg/dL were associated with an independent lower risk for all-cause and CVD mortality. A healthy diet score 69.3 or higher was associated with an independent lower risk for all-cause mortality. By contrast, an untreated total cholesterol less than 200 mg/dL was associated with an independent higher risk for cancer mortality ([Table 3](#zoi190504t3){ref-type="table"}).

We also performed stratified analyses by age, sex, race/ethnicity, education, and alcohol consumption (eTables 4, 5, 6, 7, and 8 in the [Supplement](#note-ZOI190504-1-s){ref-type="supplementary-material"}). Significant interaction between the revised LS7 metrics and age was observed for cancer mortality (eFigure 3 in the [Supplement](#note-ZOI190504-1-s){ref-type="supplementary-material"}; *P* for interaction = .002), and significant interactions between the revised LS7 metrics and education were observed for all-cause and CVD mortality (*P* for interaction = .03 and *P* for interaction = .04, respectively). The associations between the number of revised LS7 metrics and all outcomes were more pronounced in younger participants (eTable 4 in the [Supplement](#note-ZOI190504-1-s){ref-type="supplementary-material"}) and female participants (eTable 5 in the [Supplement](#note-ZOI190504-1-s){ref-type="supplementary-material"}). In another sensitivity test, 551 participants whose outcomes occurred during the first 5 years of follow-up were excluded. The results in the remaining sample remained similar to those observed in the full sample (data not shown).

[Table 3](#zoi190504t3){ref-type="table"} also presents the PAF for the individual revised ideal LS7 metrics. The PAF analysis indicated that 68.4% (95% CI, 63.1%-73.0%) of all-cause mortality, 69.9% (95% CI, 31.2%-88.6%) of cancer mortality, and 48.9% (95% CI, 28.7%-63.3%) of CVD mortality were associated with nonadherence to the revised combined ideal LS7 metrics ([Figure 2](#zoi190504f2){ref-type="fig"}), whereas 58.6% (95% CI, 33.2%-76.1%) of all-cause mortality, 63.9% (95% CI, 28.0%-84.1%) of cancer mortality, and 44.3% (95% CI, 0%-76.0%) of CVD mortality were associated with nonadherence to the combined AHA-recommended ideal LS7 metrics ([Figure 2](#zoi190504f2){ref-type="fig"}). Blood pressure was the most significant individual factor associated with all-cause mortality (PAF = 37.4%), cancer mortality (PAF = 36.7%), and CVD mortality (PAF = 47.5%) ([Table 3](#zoi190504t3){ref-type="table"}; eFigure 2 in the [Supplement](#note-ZOI190504-1-s){ref-type="supplementary-material"}).

Discussion {#H1-4-ZOI190504}
==========

Compared with the AHA-derived LS7, the revised LS7 more clearly demonstrated an associated reduction in the risk of cancer mortality. No significant dose-response association was observed between the AHA-derived LS7 metrics and cancer mortality, suggesting that the revised metrics are more strongly associated with cancer mortality than the AHA-derived metrics. Abdominal fat, such as visceral adipose tissue and subcutaneous adipose tissue, was positively associated with all-cause and cancer mortality rather than the CVD-related death in a prospective study.^[@zoi190504r19]^ The diet components recommended by AHA only focused on the promotion of cardiovascular health^[@zoi190504r1]^; however, dietary components in the Healthy Eating Index--2010 are more comprehensive.^[@zoi190504r13]^ This may partly explain why the combined revised LS7 metrics are more strongly associated with cancer mortality.

A 68.4%, 69.9%, and 48.9% reduction in relative risk of all-cause, cancer, and CVD mortality could be attributed to the ideal revised LS7 metrics, respectively. In the fully adjusted model, participants with a BMI less than or equal to 29.9 but without central obesity had a decreased risk of all-cause and CVD mortality. However, the AHA recommendation of a BMI less than 25 was not associated with all-cause and CVD mortality in a previous study.^[@zoi190504r3]^ Using the same data, central obesity was found to correlate with a higher risk of CVD mortality in normal-weight participants compared with those without central obesity (in BMI category).^[@zoi190504r14]^ Similarly, a higher risk of mortality was observed in patients with coronary artery disease and a large WHR regardless of BMI.^[@zoi190504r20]^ In our study, we observed only a weak correlation of BMI with WHR (correlation coefficient = 0.21), implying that WHR and BMI provide different information.

Our findings further indicate the additional significance of the WHR beyond BMI. The WHR is a robust indicator of visceral fat, whereas the BMI reflects general adiposity. An increased WHR parallels either a greater accumulation of the intra-abdominal fat mass or a greater decrease in the gluteofemoral muscle mass,^[@zoi190504r21]^ and intra-abdominal fat has been associated with CVD mortality.^[@zoi190504r21]^ Overweight or obese participants may carry a greater proportion of subcutaneous fat in the hips and legs, which is less associated with adverse outcomes compared with visceral fat.^[@zoi190504r22]^ In contrast to subcutaneous fat, visceral adipose tissue is associated more strongly with adverse metabolic risk factors independent of BMI and waist circumference.^[@zoi190504r23]^

A healthy diet score greater than or equal to 69.3 was independently associated with a reduced risk of all-cause mortality in our study. However, the achievement of 2 or more dietary components as defined by the AHA was not associated with all-cause mortality.^[@zoi190504r12]^ Neither a healthy diet score of 69.3 or greater or 2 or more dietary components was found to be associated with CVD and cancer mortality in a previous study.^[@zoi190504r12]^ Most studies of the healthy diet score considered the separate components of diets. However, as dietary components act collaboratively rather than individually, the dietary pattern is more representative of the total quality than the individual intakes.

A total cholesterol level less than 200 mg/dL was independently associated with a higher risk of cancer mortality in our study. Consistent with our findings, other researchers reported an inverse association between a low serum cholesterol level and increased cancer mortality.^[@zoi190504r24],[@zoi190504r25]^ However, unknown and unmeasured confounding factors affecting mortality and preexisting disease at baseline might contribute to the observed increase in mortality.^[@zoi190504r26]^ Still, the inverse association in our study remained after further excluding participants whose outcomes occurred during the first 5 years of follow-up.

In our study, BP was the most significant personal contributor, associated with 36.7% or more of the PAF. An untreated BP less than 120/80 mm Hg was associated with a reduced risk of all-cause and CVD mortality under both the AHA-defined and revised LS7 metrics.^[@zoi190504r3]^ Untreated BP less than 120/80 mm Hg was associated with an HR for all-cause mortality of 0.73 (95% CI, 0.61-0.88) and HR for CVD mortality of 0.56 (95% CI, 0.38-0.81) in our study, in contrast with 0.81 (95% CI 0.68--0.95) for all-cause mortality and 0.64 (95% CI, 0.47-0.86) for CVD mortality in the study by Yang et al.^[@zoi190504r3]^

Participants who were younger and female were more likely to meet a greater number of ideal LS7 health metrics. The significant interactions observed between the ideal revised LS7 metrics and age on cancer mortality, and between the ideal revised LS7 metrics and education on all-cause and CVD mortality, suggest that the LS7 should be promoted more strongly among high-risk groups.

When reestablishing our revised LS7 metrics, we emphasized the conjunction of WHR and BMI, an integrated dietary pattern (Healthy Eating Index--2010), and a new BP threshold for hypertension.^[@zoi190504r8]^ A strength of our study involves the use of standardized data from a large representative sample of US adults. The NHANES applies stronger criteria to guarantee minimal nonsampling and measurement errors during survey planning, data collection, and processing. A sensitivity analysis ensured the reliability of our findings. We carefully adjusted for potential confounding factors and applied stringent exclusion criteria to reduce potential bias due to reverse causation.

Limitations {#H2-6-ZOI190504}
-----------

This study has some limitations, so our findings should be interpreted cautiously. The comparison is not direct, because few participants met all of the 6 to 7 revised LS7 metrics in our study, so 7 groups were collapsed into 5 groups (0-1, 2, 3, 4, and 5-7); however, 6 groups (0-1, 2, 3, 4, 5, and 6-7) were classified for the AHA-recommended version.^[@zoi190504r3]^ Second, the physical activity levels, smoking history, and dietary records were self-reported in the NHANES surveys, which may have introduced recall bias. Third, the revised LS7 metrics were only available at baseline, and long-term changes (eg, trajectories) in LS7 metrics could not be captured. Misclassification error of underlying and contributing causes of death and residual confounding and competing risks for cause-specific mortalities should also be noted. In addition, because genetic data were not available, the potential impact of genetic backgrounds in participants of different races/ethnicities on the association between revised LS7 metrics and risks of mortality outcomes were not investigated. Furthermore, the potential misclassification of the scoring approach in our study could not be avoided.

Conclusions {#H1-5-ZOI190504}
===========

Our study indicated that few US adults met 6 to 7 ideal revised LS7 metrics. For participants with BMI less than or equal to 29.9 but without central obesity, the revised metrics were independently associated with decreased risk of all-cause and cardiovascular disease mortality. The individual revised LS7 metrics with modified criteria regarding weight, BP, and diet provide more information about factors associated with cancer mortality than the original AHA-derived LS7 metrics.
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